High incidence of complications from enoxaparin treatment after arthroplasty. - Test2 - elhamkhani - TriplyDB

High incidence of complications from enoxaparin treatment after arthroplasty.

High incidence of complications from enoxaparin treatment after arthroplasty.

http://www.wikidata.org/entity/Q37483311

about

CT pulmonary angiography after total joint arthroplasty: overdiagnosis and iatrogenic harm?Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.TWO CLASSIFICATIONS FOR SURGICAL WOUND HEMATOMA AFTER TOTAL HIP REPLACEMENT.

P2860

Q30410953-468298C3-0E5B-479C-8E25-CDCFBA0F644A Q35958939-6BA09524-DD06-4FAE-8981-B055C0E6B227 Q37563834-DB560990-9D27-4AC1-B33E-B5C8B73B57FC Q55438284-F244C615-7526-457D-919E-CDA60D38DC03

P2860

High incidence of complications from enoxaparin treatment after arthroplasty.

http://www.wikidata.org/entity/Q37483311

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High incidence of complications from enoxaparin treatment after arthroplasty.

@en

High incidence of complications from enoxaparin treatment after arthroplasty.

@nl

type

label

High incidence of complications from enoxaparin treatment after arthroplasty.

@en

High incidence of complications from enoxaparin treatment after arthroplasty.

@nl

prefLabel

High incidence of complications from enoxaparin treatment after arthroplasty.

@en

High incidence of complications from enoxaparin treatment after arthroplasty.

@nl

P1433

Q37483311-0D148CC5-9B68-4AA4-8D24-0B5F6EC43E24

P1476

Q37483311-26867536-DFB5-4B97-9C13-8082218B68F7

P2093

Q37483311-30E52BF2-1C10-4E77-90CE-91D7D846E32B

Q37483311-567F185C-76AF-435F-8A99-A101A27137DE

Q37483311-65EE44F8-A179-4F26-A0E3-432459A0FF1A

Q37483311-B37362FF-E0DE-4C5E-A719-26CA4E6F7EC8

Q37483311-FC39BDF8-3AB0-4C16-8DED-4427E6D7B33B

P2860

Q37483311-01F77EE2-C8F8-4E1B-B8F9-C04CDF33F592

Q37483311-03EB8DA7-82DD-41CC-92CD-5C7A59DD2135

Q37483311-0ED384D3-66B3-4A4B-975C-D1F2847AFBF4

Q37483311-0F93F3B9-819B-46CD-B313-BE15D0605C88

Q37483311-2AE6B52D-5397-414E-A707-F3EB07F626E9

Q37483311-2EA6FB85-A8AB-4FE4-9B53-E1D89386A3CD

Q37483311-34013BB3-C764-4D5B-BB0F-5654CF68A66D

Q37483311-3DAD6533-4E27-4E97-AFAA-BCEF23F9682F

Q37483311-4506EF39-26E1-4D08-B45E-D51A61E5406B

Q37483311-45C4C27A-16E8-46D4-B427-15BA9D79783A

P2888

Q37483311-5857DE1D-04D6-4E38-8713-3A720421CD24

P304

Q37483311-EF8D5A93-7A54-4C1D-B626-3F1B6EBB26A3

P31

Q37483311-19B9F003-C07E-4340-8917-8B353DD68D70

P356

Q37483311-FA4257BD-2688-45EC-9F54-A499BCCC6666

P407

Q37483311-68941548-0A6F-4EC2-AE38-90A8B8B50631

P433

Q37483311-894D6B67-DE44-4610-B48B-380843B7736D

P478

Q37483311-BFD5D78B-6AEA-4297-844D-40989BED5F7D

P577

Q37483311-5F8D285F-F779-44B4-B7DA-6E996B129BF8

P5875

Q37483311-6BE92812-4F4E-406F-BB19-736429190587

P698

Q37483311-3A4AA547-96BC-48E8-8A43-D611C9DCA56E

P932

Q37483311-2A0E56FE-E148-4796-BD6A-32E08C005279

P356

S11999-009-1020-6

P1433

Clinical Orthopaedics and Related Research

P1476

High incidence of complications from enoxaparin treatment after arthroplasty.

@en

P2093

Alejandro Gonzales Della Valle

http://www.w3.org/2001/XMLSchema#string

Andrew S Neviaser

http://www.w3.org/2001/XMLSchema#string

Charles Chang

http://www.w3.org/2001/XMLSchema#string

Stephen Lyman

http://www.w3.org/2001/XMLSchema#string

Steven B Haas

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of anticoagulation on the restoration of range of motion after total knee arthroplasty: enoxaparin versus aspirin

Routine duplex ultrasound screening after TKA is not necessary

Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Complications of heparin therapy after total joint arthroplasty.

Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States

Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement.

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

P2888

s11999-009-1020-6

P304

115-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11999-009-1020-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

468

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26731411

http://www.w3.org/2001/XMLSchema#string

P698

19669848

http://www.w3.org/2001/XMLSchema#string

P932

2795811

http://www.w3.org/2001/XMLSchema#string